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ttp://dx.doi.org/10.1016/j.ajpath.2014.03.016The silent mating type information regulation 2 homolog 1 gene (Sirt1) encodes an NAD-dependent
deacetylase that modiﬁes the activity of well-known transcriptional regulators affected in kidney dis-
eases. Sirt1 is expressed in the kidney podocyte, but its function in the podocyte is not clear.
Genetically engineered mice with inducible and reversible Sirt1 knockdown in widespread, podocyte-
speciﬁc, or tubular-speciﬁc patterns were generated. We found that mice with 80% knockdown of
renal Sirt1 expression have normal glomerular function under the basal condition. When challenged
with doxorubicin (Adriamycin), these mice develop marked albuminuria, glomerulosclerosis, mito-
chondrial injury, and impaired autophagy of damaged mitochondria. Reversal of Sirt1 knockdown during
the early phase of Adriamycin-induced nephropathy prevented the progression of glomerular injury and
reduced the accumulation of dysmorphic mitochondria in podocytes but did not reverse the progression
of albuminuria and glomerulosclerosis. Sirt1 knockdown mice with diabetes mellitus, which is known to
cause mitochondrial dysfunction in the kidney, developed more albuminuria and mitochondrial
dysfunction compared with diabetic mice without Sirt1 knockdown. In conclusion, these results
demonstrate that our RNA interferenceemediated Sirt1 knockdown models are valid and versatile tools
for characterizing the function of Sirt1 in the kidney; Sirt1 plays a role in homeostatic maintenance of
podocytes under the condition of mitochondrial stress/injury. (Am J Pathol 2014, 184: 1940e1956;
http://dx.doi.org/10.1016/j.ajpath.2014.03.016)Supported by NIH grants 1R01DK078897 and 1R01DK088541-01A1
(P.Y.C.) and 5K08DK082760 (J.H.C.) and Veterans Affairs Merit Re-
view Award 1I01BX000345 (J.C.H.).
Disclosures: P.K.P. is the Chief Executive Ofﬁcer and a shareholder of
Mirimus, Inc., which specializes in engineering customized mouse
models with reversible gene silencing.Sirtuin 1 (Sirt1) is a member of the sirtuin family of protein
deacetylases that require NADþ as a cofactor for enzymatic
function. Sirt1 deacetylates and regulates the activity of
transcription factors, including p53, FOXO, RelA, STAT3,
PGC1a, and peroxisome proliferatoreactivated receptor.1
On the cellular level, Sirt1 functions to control autophagy,2
energetic homeostasis,3,4 mitochondrial biogenesis,5 and
apoptosis.6e8 In mammals, Sirt1 participates in glucose and
lipid metabolism through its action in pancreatic b cells,9,10
hepatocytes,11e13 and adipose tissue.14
Sirt1 in renal tubular cells has been shown to protect renal
tubular cells from cellular stresses associated with aging,
cisplatin, and hypoxia.15e17 More recently, renal tubularstigative Pathology.
.Sirt1 expression was reported to mitigate diabetic podocyte
injury.18 Although Sirt1-mediated deacetylation is capable
of modulating signaling ﬂux through well-described path-
ways affected in kidney diseases, studies of Sirt1 activity in
glomerular cells and glomerular biology are still in the early
phases of exploration. In the past, we reported that Sirt1
expression is decreased in glomeruli of patients with
RNAi Knockdown of Sirt1 in Renal Cellsdiabetic nephropathy.19 More recently, we demonstrated
that diabetic mice with podocyte-speciﬁc Sirt1 deletion
develop accelerated diabetic nephropathy.20 Consistent with
our ﬁndings, others also demonstrated a pathogenic role for
Sirt1 deﬁciency in diabetic nephropathy.18,21e23 With the
aim of developing robust and versatile murine models for
evaluating Sirt1’s function in podocytes and tubular cells
under the basal condition and in glomerular diseases, we
engineered genetically modiﬁed mice with inducible,
reversible, and tissue-speciﬁc Sirt1 knockdown.
Herein, we described the production and validation of
transgenic mice with doxycycline (DOX)einducible RNA
interference (RNAi)emediated knockdown of Sirt1 in
nearly all tissues and in speciﬁc kidney cells (podocytes or
tubular cells). We found that Sirt1 is dispensable for kidney
and glomerular development. Under the basal condition,
Sirt1 deﬁciency has no impact on glomerular function.
However, under conditions of mitochondrial stress, due to
either doxorubicin [Adriamycin (ADR)]einduced genotox-
icity or diabetes-related disruption of mitochondrial dy-
namics, we observed that Sirt1 is necessary for autophagy of
damaged mitochondria in podocytes to maintain the ultra-
structure and function of the glomerular ultraﬁlter.Materials and Methods
Transgenic Mouse Models
Animal studies were performed in accordance with the
guidelines of and approved by the Institutional Animal Care
and Use Committee at the Icahn School of Medicine at
Mount Sinai (New York, NY).
In Vivo RNAi Models for Inducible and Reversible Sirt1
Knockdown
We generated transgenic mice with inducible and reversible
knockdown of Sirt1 by adapting a DOX-inducible RNAi
model24 to speciﬁcally target Sirt1. First, we computationally
predicted four shRNA guide sequences to target Sirt1 (refer-
ence NM_019812.2). Guide sequences were embedded
within the miR-30ebased expression cassette of a retroviral
shRNA vector (Supplemental Figure S1A). Knockdown ef-
ﬁciency of Sirt1 guide sequences was determined by trans-
ducing mouse podocytes with retroviral shRNA vectors.
Knockdown efﬁciency of Sirt1-speciﬁc guide sequences was
determined by comparing with a control guide sequence tar-
geting the ﬁreﬂy luciferase gene24 (shLuci). Two lines of
genetically engineered mice, corresponding to the Sirt1.688
and Sirt1.2191 guide sequences, were generated using the
ColA1 Flp/FRT recombinase-mediated targeting system.24 A
single copy of the Flp-In targeting vector was inserted
downstream of the ColA1 gene in engineered KH2 ES cells,
which contain an FRT-hygro-pA homing cassette. The Flp-In
targeting vector, called pCol-TGM, was conﬁgured with a
green ﬂuorescent protein (GFP) spacer between a tetracycline-
regulated element and the miR-30ebased expression cassette.The American Journal of Pathology - ajp.amjpathol.orgThe GFP spacer sequence functions as a ﬂuorescent reporter
of shRNA expression because GFP and the shRNAmir are
co-expressed as a single fusion transcript from pCol-TGM.
Engineered ES cells with pCol-TGM insertion were selected
and then used to generate transgenic mice, called TGM mice,
by tetraploid blastocyst microinjection. Heterozygous TGM
mice were bred to a line of transgenic mice that express the
reverse tetracycline-controlled transactivator (rtTA) under the
control of a strong synthetic promoter called CAGs (cyto-
megalovirus early enhancer element and chicken b-actin).24
Double-transgenic mice with the CAGs-rtTA and TGM
transgenes, called CAGs;Sirt1RNAi, exhibit DOX-inducible
TGM expression in a widespread manner.
Mice with Inducible Podocyte- and Tubular-Speciﬁc Sirt1
Knockdown
To generate mice with inducible Sirt1 knockdown in podocytes
and tubular cells, we bred heterozygous Col-TGM mice to
NPHS2-rtTA25 and Pax8-rtTA26 mice (both were purchased
from Jackson Laboratory, Bar Harbor, ME). Mice with
podocyte-restricted and tubular cellerestricted Sirt1 knock-
down are called POD;Sirt1RNAi and TUB;Sirt1RNAi, respec-
tively.Micewith inducible and podocyte-speciﬁc expression of
shLuci targeting theﬁreﬂy luciferase gene, calledPOD;LucRNAi
mice, were generated by breeding NPHS2-rtTAmice to shLuci
ColTGM mice.24 Details of construct design and transgenesis
have described elsewhere.24 The genetic background of
CAGS;Sirt1RNAi, POD;Sirt1RNAi, and TUB;Sirt1RNAi mice
consists of contributions from C57BL/6, FVB, and 129 strains.
Induction of Sirt1 Knockdown
To induce Sirt1 knockdown, CAGs;Sirt1RNAi mice were fed
200 mg/kg DOX-supplemented chow (Bio-Serv, French-
town, NJ). To induce Sirt1 knockdown in POD;Sirt1RNAi
and TUB;Sirt1RNAi mice, 200 mg/kg DOX-supplemented
chow (Bio-Serv) and 0.2 mg/mL DOX-supplemented
drinking water were given concurrently. Duration of DOX
feeding is speciﬁed in the Results and ﬁgure legends.
Conditional Knockout Mice with Podocyte-Speciﬁc Sirt1
Deletion (PODDSirt1)
Sirt1 loxPmice27 were bred toNPHS2-Cremice28 to generate
mice that are compound heterozygous for the NPHS2-Cre
transgene and the Sirt1 ﬂoxed allele. Subsequent F1  F1
crossings of these compound heterozygous mice yielded mice
that were heterozygous for the NPHS2-Cre transgene and
homozygous for the Sirt1 ﬂoxed allele (PODDSirt1).
Sirt1 Gene Knockout Mice
Heterozygous Sirt1 exon 4 gene knockout mice29 have been
described elsewhere.30ADR-Induced Nephropathy
Adriamycin (Sigma-Aldrich, St. Louis, MO) was diluted in
sterile 0.9% sodium chloride solution. Sensitivity to ADR1941
Chuang et alnephropathy was assessed in a dose-response experiment. The
i.v. administration of 12.5 mgADR/kg of bodyweight did not
cause proteinuria in male CAGS;Sirt1RNAi, POD;Sirt1RNAi,
and TUB;Sirt1RNAi mice without DOX-induced Sirt1 knock-
down. With 18.8 mg/kg of ADR, all three lines of mice
without DOX-induced Sirt1 knockdown developed a signif-
icant increase in urinary albumin excretion (0.08 0.006 mg/
mg pre-injection versus 0.801  0.081 mg/mg 10 days after
injection; P < 0.05). Therefore, a dose of 18.8 mg/kg was
chosen for these experiments.
Multiple Low-Dose STZ-Induced Diabetes Model
Induction of diabetes using streptozotocin (STZ; Sigma-
Aldrich) has been described previously.31,32 Brieﬂy, mice
between 6 and 8 weeks of age were fasted for 4 hours before
i.p. injection of 50 mg/kg of body weight STZ diluted in 50
mmol/L sodium citrate buffer (pH 5.4). Fasting and STZ in-
jection were repeated on 5 consecutive days. Two weeks after
the ﬁrst day of STZ injection, a 6-hour fast blood glucose level
from the tail vein was measured using the One Touch Blood
Glucose Monitoring system (Lifescan, Inc., Milpitas, CA).
Repeat glucose measurements were taken at least every 4
hours to verify that hyperglycemiawasmaintained. Successful
modeling of STZ-induced diabetes was deﬁned as sustained
fasting glucose level>250mg/dL onmore than two occasions
2 to 3 weeks after STZ injection. Approximately 80% of the
mice developed fasting glucose >250 mg/dL 4 weeks after
STZ injection. Four of thesemicewere fed aDOXdiet 4weeks
after STZ injection (STZþDOX),whereas the other fourmice
were fed a normal chow diet (STZ) until 26 weeks of age.
Tail Cuff Noninvasive Blood Pressure
Blood pressure was measured by CODA noninvasive tail
cuff blood pressure system (Kent Scientiﬁc, Torrington, CT).
Antibodies
Arabbit antibody toWilms tumor (WT)-1 and a rabbit antibody
to nephrin were purchased from Novus Biologicals (Littleton,Table 1 List of Real-Time PCR Primers
Gene Forward primer
18s rRNA 50-TGCATGGCCGTTCTTAGTTG-30
Cd2ap 50-TGGTGGAGTGGAACCCTGAA-30
COX1 50-TGCTAGCCGCAGGCATTACT-30
Cox8a 50-TCCGGCTGGTTCGGCCATCT-30
Gapdh 50-GCCATCAACGACCCCTTCAT-30
Mpv17 50-GCAGCACATCCGTGGAAAGT-30
Nd1 50-TGCACCTACCCTATCACTC-30
Nd4 50-ATAATTATAACTAGCTCAATCTGC-
Ndufa4 50-AGCCAGGTTGCAGAAGCGGC-30
Neph1 50-TCACAAGCAGGGCTTTAGGA-30
Neph2 50-AGGACCACGGTGGACTACA-30
Nphs1 50-GTGCCCTGAAGGACCCTACT-30
Nrf1 50-AGAAACGGAAACGGCCTCAT-30
1942CO). A rat antibody to podocalyxin was purchased from R&D
Systems (Minneapolis, MN). A mouse antibody for Sirt1 was
purchased from Millipore (Billerica, MA). A mouse antibody
for GFP and a mouse antibody for TOM20 were purchased
from Santa Cruz Biotechnology, Inc. (Dallas, TX). A rabbit
antibody for p62/SQSTM1 and a rabbit antibody for LC3were
purchased from Cell Signaling Technology (Beverly, MA). A
rabbit antibody for parkin was purchased from Abcam (Cam-
bridge, MA). A rabbit antibody for nephrin was a gift from
Dr. Larry Holzman (University of Pennsylvannia, Philadel-
phia, PA) Mitochondrial staining was performed using Mito-
Tracker Red FM (Life Technologies, Carlsbad, CA).
Western Blot Analysis
Western blot analysis was performed as previously de-
scribed.19 Each lane contained 60 to 100 mg of total protein.
Semiquantitative assessment of band density was performed
using ImageJ software version 1.43 (NIH, Bethesda, MD).
Band density for the protein of interest was normalized to
either glyceraldehyde-3-phosphate dehydrogenase (GAPDH)
or b-actin.
Quantitative Real-Time PCR
Real-time PCR was performed as previously described.33 For
each gene target, at least two technical replicates were mea-
sured. CT values of the gene targets were normalized to
GAPDH. Fold change in expression of target genes compared
with the reference group was calculated using the 2DDCT
method, with GAPDH as the calibrator. Primers were designed
using Primer-BLAST34 to span at least one intron. Mitochon-
dria/nuclear DNA ratios were quantiﬁed by real-time PCR and
presented as a ratio ofmitochondria-encodedcyclooxygenase1/
nuclear-encoded 18s rRNA. Primer sequences are in Table 1.
Immunostaining and Imaging
Staining and image acquisition were performed as previously
described.33 Images of mitochondrial morphological charac-
teristics were obtained using a Leica TCS SP5II confocalReverse primer
50-TAGCATGCCGAGATGCTCGTT-30
50-GTGAGGTAGGGCCAGTCAAA-30
50-CGGGATCAAAGAAAGTTGTGTTT-30
50-CCAGCCCGCAGGCAGAAGAC-30
50-ATGATGACCCGTTTGGCTCC-30
50-CCAGCTGCTGTGAGATCATGT-30
50-ATTGTTTGGGCTACGGCT-30
30 50-TCGTAGTTGGAGTTTGCTAG-30
50-GCTGCTCCAGTACCCCCTGC-30
50-CTGGCTGAAGCGAGTCTGAG-30
50-TCTACCAGCAGTGACTGAGGC-30
50-CCTGTGGATCCCTTTGACAT-30
50-CATCCAACGTGGCTCTGAGT-30
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RNAi Knockdown of Sirt1 in Renal Cellsmicroscope (Leica Microsystems, Inc., Concord, ON, Can-
ada). Stacked ﬂuorescence images of TOM20 and parkin
stainingwere acquired using a Zeiss Axioplan2 IEmicroscope
(Carl Zeiss, Thornwood,NY). Post-processing to deconvolute
stacked images was performed using the AutoQuant X2.2.1
software package (Rockville, MD).
Tissue Histological and Morphometric Data
Kidney sections were ﬁxed and embedded in either parafﬁn
or Tissue-Tek Optimal Cutting Temperature compound
(Sakura Finetek USA, Inc. Torrance, CA), as previously
described.33 For transmission electron microscopy (TEM),
kidney cortex samples ﬁxed in 2.5% glutaraldehyde were
divided into sections, mounted on a copper grid, and then
images were imaged using a Hitachi H7650 microscope
(Hitachi, Tokyo, Japan), as previously described.31 Quanti-
ﬁcation of foot process (FP) width was performed using
ImageJ software on digitized TEM images, as previously
described.31 For quantiﬁcation of FP width, two mice per
group, ﬁve glomeruli per mouse, and>600 mm of glomerular
basement membrane length were assessed per mouse.
Detection of Senescence-Associated b-Galactosidase
Activity
Frozen kidney tissue embedded in OCT compound was
divided into sections (4 mm thick). Tissue activity of
senescence-associated b-galactosidase was determined by
histochemical detection of senescent cells at pH 6.0, as pre-
viously decribed.35 Frozen kidney sections of mice with
ADR-induced nephropathy, which demonstrated b-galacto-
sidase activity in tubular cells, were used as positive controls.
Urine Albumin and Protein Analyses
Urine albumin was quantiﬁed using an ELISA kit (Bethyl
Laboratory, Houston, TX). Urine creatinine was measured in
the sameurine sample as urine albumin using theQuantiChrom
CreatinineAssayKit (DICT-500;BioassaySystems,Hayward,
CA). Coomassie Blue staining of 5 mL of urine denatured with
Laemmli sample buffer and resolved on an 8% SDS poly-
acrylamide gel was performed as previously described.33
Measurement of Serum Urea Nitrogen and Creatinine
Serum samples were stored at 80C until measurement.
Serum urea nitrogen content was measured using a commer-
cially available kit (Bioassay Systems). Serum creatinine was
quantiﬁed by a high-performance liquid chromatographye
based method, as previously published.36 Serum (5 mL per
mouse) was processed as previously described. A Shimadzu
Prominence high-performance liquid chromatography unit
(Shimadzu Scientiﬁc Instruments, Columbia, MD) and a
Hamilton cation exchange column (model PRP-X200; Ham-
ilton Company, Reno, NV) were used.The American Journal of Pathology - ajp.amjpathol.orgRenal Biopsy Specimen
Survival surgical procedures were performed to obtain a bi-
opsy specimen of the right and left kidneys through ﬂank
incisions. A biopsy was performed of approximately 1.5 mm
of the lower pole of the right kidney before the introduction of
a DOX diet. Fourteen days later, a biopsy was performed of
1.5mm of the lower pole of the left kidney. At the termination
of the study, 1.5 mm of the upper pole of the right kidney was
sampled. Kidney samples were stored in RNAlater (Qiagen,
Valencia, CA) until RNA extraction or processed for total
protein extraction, as described for Western blot analysis.
Next-Generation Sequencing
Total RNA was extracted from a biopsy specimen of kidney
cortex samples using an RNAeasy mini kit (Qiagen). Next-
generation sequencing of mRNA captured using polyA se-
lection was performed by the Genomics Core Facility at the
Icahn School of Medicine at Mount Sinai using the Illumina
HiSeq Sequencing Platform (San Diego, CA). Raw readings
from RNA sequencing were analyzed using a TopHat/Cuf-
ﬂinks pipeline for transcript assembly and quantiﬁcation.37
Glomerular Isolation and PGEC Culture
Glomeruli from mice were isolated by perfusion of magnetic
particles, as described,38 with minor modiﬁcations. Brieﬂy,
isolated glomeruli were transferred onto a 6-cm tissue culture
dish coated with type I collagen and cultured in RPMI 1640
medium (Life Technologies) supplemented with 10% fetal
bovine serum and 1% penicillin/streptomycin. DOX was
added to the culture medium to achieve a ﬁnal concentration
of 2 mg/mL, where speciﬁed. Glomeruli and cells were
allowed to attach to the plate for 5 days in a 37C incubator
without any agitation. Five days later, glomeruli and
outgrowth cells were detached from the plate using a 0.12%
trypsin-EDTA solution. Trypsinized cells [primary glomer-
ular epithelial cells (PGECs)] were strained using a 40-mm
cell strainer and replated onto collagen-coated dishes. PGECs
were allowed to grow to 80% conﬂuence before passaging at
a ratio of 1:3. PGECs are cells derived from decapsulated
glomeruli, isolated by perfusion of magnetic particles.
PGECs consist mostly of podocytes, with approximately
70% of PGECs being positive for podocalyxin staining.
Fluorescence-Activated Cell Sorting of GFP-Labeled
Podocytes
To isolate GFP-positive podocytes from POD;Sirt1RNAi and
POD;LucRNAimice, we ﬁrst isolated glomeruli, as previously
described. Fluorescence-activated sorting of podocytes was
performed as described previously.39 Brieﬂy, isolated
glomeruli were digested into a single-cell suspension using a
buffered solution containing collagenase II, proteinase E, and
DNase I, as described previously. Podocytes were isolated1943
Figure 1 In vivo RNAi model with inducible
Sirt1 knockdown. A: Double-transgenic CAGs.
Sirt1RNAi mice harbor two transgenes: TGM and
CAGs-rtTA. B: Representative Western blot analyses
of Sirt1, GFP, and GAPDH on kidney protein lysates
from two different lines of CAGs;Sirt1RNAi mice,
with or without 5 days of DOX feeding, starting at
8 weeks of age. Each lane represents one mouse. C:
Normalized Sirt1 band density from Western blot
analyses in B. D: Immunostaining of WT-1 on
kidney sections of CAGs;Sirt1RNAi mice, with and
without DOX feeding. Dashed line in the lowest
panel outlines WT-1epositive cells. Representative
Western blot analyses of Sirt1 in PGECs isolated
from CAGs-only control mice and CAGs;Sirt1RNAi
mice. E: PGECs were cultured with and without 2
mg/mL DOX for 3 days. F: Normalized Sirt1 mRNA
transcript levels of PGECs cultured with and
without DOX. *P < 0.05. Scale bar Z 50 mm (D).
CAGG, CMV-enhanced chicken b-actin promoter;
Hygro, hygromycin resistance gene; I, interstitial
cells; P, WT-1epositive podocytes; PGK, phos-
phoglycerate kinase 1 promoter; rtTA3, third-
generation reverse tet-transactivator; SAdpA
(stop), splicing acceptor donor polyA sequence; T,
tubular cells; TRE, tetracycline-regulated element.
Chuang et alusing an FACSAria II cell sorter (laser excitation, 488 nm;
power, 200 MW; and sheath pressure, 20 to 30 psi using a
100-mm nozzle). DAPI staining was performed to exclude
damaged cells stained with DAPI.
Cell Lines
Murine Podocyte Cell Line
A conditionally immortalized murine podocyte cell line
used to test knockdown efﬁciency of Sirt1 shRNA guide
sequences was a gift from Dr. Peter Mundel (Massachusetts
General Hospital, Boston). Podocytes were cultured on
collagen Iecoated plates at 37C for at least 7 days before
experiments, as previously described.
Inducible Sirt1 Knockdown Podocyte Cell Line
A conditionally immortalized podocyte cell line with
DOX-inducible Sirt1 knockdown from POD;Sirt1RNAi
mice was established from GFP-positive podocytes by1944ﬂuorescence-activated cell sorting (FACS). FACS-isolated
podocytes were allowed to attach to a collage Iecoated tis-
sue culture dish for 12 hours. Isolated cells were transduced
with a lentivector that expressed a temperature-sensitive SV40
T/t antigen, then maintained and propagated at 33C permis-
sive growth condition. Cells were thermoshifted to 37C and
maintained for 1 week before experiments. Approximately
70% of the FACS-isolated podocytes expressed GFP on DOX
induction (2 ng/mL of culture medium after 3 days’ incuba-
tion). Conditionally immortalized cells used in the experi-
ments herein were passaged less than ﬁve times.
Statistical Analysis
Data are expressed as means  SEM. Statistical analyses
were performed using GraphPad Prism version 5.0a (La
Jolla, CA). For comparison of means between groups, one-
way analysis of variance was performed, followed by a
Tukey post-test using a signiﬁcance cutoff of P < 0.05.ajp.amjpathol.org - The American Journal of Pathology
Figure 2 Renal gene expression, function, and
histological features of mice with chronic Sirt1
knockdown. A: Representative Western blot ana-
lyses of Sirt1, GFP, and b-actin of age-matched
CAGs;Sirt1RNAi mice with and without 11 weeks of
DOX feeding. The arrow indicates the Western blot
band corresponding to Sirt1. B: Glomerular ex-
pressions of Sirt1, markers of cellular senescence
(ARF and p16INK4a), and podocyte-speciﬁc genes
(Nphs1, Synpo, CD2AP, WT-1, Neph1, and Neph2)
in mice with and without 11 weeks of DOX feeding.
NZ 4 mice per group. Black bars, DOX; white bars,
no DOX. C: UACR of CAGs;Sirt1RNAi mice before and
after 11 weeks of DOX feeding. Serum urea nitro-
gen (D) and serum creatinine (E) of CAGs;Sirt1RNAi
mice after 11 weeks of DOX compared with those
not fed with DOX. N Z 4 to 5 mice per group. F:
Staining for b-galactosidase activity assessed at a
pH of 6.0 (known as senescence-associated b-
galactosidase activity) on frozen kidney sections
of CAGs;Sirt1RNAi mice with and without 11 weeks
of DOX feeding. Staining of a section of mice with
ADR nephropathy (ADR-N) served as a positive
control. Arrowheads indicate tubular cells with
positive staining. GeL: Representative images of
kidney glomeruli, podocyte, podocyte foot pro-
cesses, mesangial cell, glomerular endothelium,
and tubular cell of CAGs;Sirt1RNAi mice after 11
weeks of DOX feeding. *P < 0.05. Scale bars: 50
mm (F and G); 2 mm (HeL). Pos., positive.
RNAi Knockdown of Sirt1 in Renal CellsResults
A Murine Model of Inducible and Reversible Sirt1
Knockdown
We adapted a DOX-inducible RNAi-mediated knockdown
model24 to target Sirt1. First, we computationally predicted
four shRNA guide sequences targeting Sirt1 (Supplemental
Figure S1A). Two of the four guide sequences, Sirt1.688The American Journal of Pathology - ajp.amjpathol.organd Sirt1.2191, exhibited >50% Sirt1 knockdown in a mu-
rine podocyte cell line (Supplemental Figure S1, B and C).
Two lines of genetically engineered mice with either the
Sirt1.688 or Sirt1.2191 guide sequence were generated. To
generate mice with robust and widespread knockdown of
Sirt1, we produced double-transgenic CAGs;Sirt1RNAi mice
in which DOX-induced TGM expression is regulated by the
strong, ubiquitous CAGs promoter (Figure 1A). CAGs;-
Sirt1RNAi mice expressing either the Sirt1.688 or Sirt1.21911945
Figure 3 Genetically engineered mice with
inducible and conditional Sirt1 knockdown in
podocytes and tubular cells. A: A scheme depicting
two lines of double-transgenic mice with inducible
Sirt1 knockdown in podocytes (POD;Sirt1RNAi) or
tubular cells (TUB;Sirt1RNAi). Podocyte-speciﬁc
knockdown was driven by a 2.5-kb NPHS2 pro-
moter, and tubular-speciﬁc knockdown was driven
by a 5.6-kb Pax8 promoter. B: A representative
ﬂuorescein isothiocyanate (FITC) ﬂuorescence
image overlapped with a phase-contrast image of
glomeruli (arrowheads) isolated from POD;Sirt1RNAi
mice. Highly arborized PGECs emanating from
glomeruli are marked with arrows. The asterisk
indicates GFP-negative PGECs outgrown from the
glomeruli. C: Normalized Sirt1 expression of GFP-
positive podocytes isolated by ﬂuorescence-
activated cell sorting from POD;Sirt1RNAi mice and
control POD;LucRNAi mice (N Z 4 mice in each
group). D: Normalized Sirt1 mRNA expression in
renal cortex of TUB;Sirt1RNAi mice with and without
DOX feeding for 5 days. N Z 3 mice per group.
*P < 0.05.
Chuang et alguide sequence exhibit robust DOX-inducible knockdown of
Sirt1 protein and mRNA transcript levels (Figure 1, B and C).
DOX treatment also induced GFP expression from the TGM
transgene, which allows tracking of cells with Sirt1 knock-
down. GFP expression was stronger in CAGs;Sirt1RNAi mice
expressing the Sirt1.688 guide sequence (Figure 1B).
Therefore, the Sirt1.688 line was used in all subsequent ex-
periments. This discrepancy in GFP expression between the
Sirt1.688 and Sirt1.2191 lines was likely due to improved
shRNAmir processing of the Sirt1.2191 guide sequence.
The pattern of GFP expression in the kidney indicates that
nearly all of the cells within the glomerular and tubu-
lointerstitial compartments of CAGs;Sirt1RNAi kidney were
targeted for Sirt1 knockdown (Figure 1D). GFP expression
was absent from renal interstitial cells and nonpodocyte
glomerular cells (Figure 1D). Colocalization of GFP with
WT-1, which is a marker of podocytes, conﬁrmed that
podocytes were targeted for Sirt1 knockdown (Figure 1D).
To assess the extent of Sirt1 knockdown in podocytes, we
isolated PGECs from CAGs;Sirt1RNAi mice and cultured
these PGECs in the presence or absence of DOX. PGECs
were also isolated from control mice with only the CAGs-
rtTA transgene (ie, CAGs-only mice). DOX treatment
signiﬁcantly reduced the protein and mRNA expression of
Sirt1 in CAGs;Sirt1RNAi PGECs (Figure 1, E and F). As
expected, Sirt1 expression was reduced and GFP expression
was present in multiple organs of DOX-fed CAGs;Sirt1RNAi
mice (Supplemental Figure S1D).
To demonstrate that shRNA-mediated knockdown ofSirt1 is
reversible onwithdrawalofDOX,weperformed transcriptome-
wide assessment of renal gene expression by next-generation
sequencing of RNA transcripts extracted from kidneys of
mice before DOX (D0), after 14 days of DOX treatment
(D14), and 14 days after discontinuing DOX treatment (D28)
(Supplemental Figure S1E). The transcript and protein levels of1946Sirt1onD14were signiﬁcantly lower than those onD0 andD28
(Supplemental Figure S1, F and G). Of all of the mammalian
sirtuins (Sirt1 to Sirt7), only the Sirt1 mRNA transcript level
was signiﬁcantly lower on D14 compared with both on D0 and
D28 (Supplemental Figure S1H), suggesting that Sirt1 knock-
down in our model was not associated with a compensatory
change in the expression of other members of the sirtuin family.
Functional Role of Sirt1 in the Kidney under the Basal
Condition
First, we examined the impact of acute Sirt1 knockdown (5
days of DOX) on the renal function of male CAGs;Sirt1RNAi
mice.We found that urinary albumin/creatinine ratio (UACR)
and serum levels of urea nitrogen and creatinine were not
signiﬁcantly different between mice with and without DOX
feeding to knockdown Sirt1 (Supplemental Figure S2, AeC).
Renal histological features were also indistinguishable be-
tween the two groups of mice (data not shown). Next, we
examined the impact of chronic Sirt1 knockdown (11 weeks
of DOX) on renal function of CAGs;Sirt1RNAi mice. Chronic
DOX feeding signiﬁcantly decreased protein and mRNA
expression of Sirt1 compared with age-matched mice without
DOX feeding (Figure 2, A and B). Urinary albumin excretion
(ie, UACR) and serum levels of urea nitrogen and creatinine
were also not signiﬁcantly different between mice with and
without chronic Sirt1 knockdown (Figure 2, CeE). Because
Sirt1 participates in the regulation of cellular senescence in
response to cellular stress,40,41 we evaluated the impact of
chronic Sirt1 knockdown on cellular senescence of renal
cells. Markers of cellular senescence, including senescence-
associated b-galactosidase activity (Figure 2F) and mRNA
transcript levels of the Cdkn2a locus (INK4a and ARF)
(Figure 2B), were not markedly different between mice
with and without Sirt1 knockdown. Furthermore, the renalajp.amjpathol.org - The American Journal of Pathology
Figure 4 Glomerular function and struc-
ture of CAGs;Sirt1RNAi mice with ADR-induced
nephropathy. A: A scheme of study design to
determine the susceptibility of CAGs;Sirt1RNAi
mice to ADR. B: A Coomasie Blueestained gel
with urinary proteins and albumin standards
resolved by SDS-PAGE. (Albumin standards:
0.05, 0.1, 0.5, 1.0, and 5.0 mg per lane). C: A
graph of UACR on D0 and D10 after ADR or
normal saline (NS) injection. N Z 5 in the
ADR-only group, N Z 6 in the ADR þ DOX
group, NZ 3 in the NS-only group, and NZ
3 in the NS þ DOX group. D: Representative
images of PAS-stained kidney sections.
Dilated tubules ﬁlled with protein casts are
present in the ADR þ DOX group. E: Repre-
sentative TEM images of podocytes (P). Red
arrows indicate areas of foot process efface-
ment. F: A bar graph representing podocyte
FP width. *P < 0.05, ***P < 0.001. Std,
standard.
RNAi Knockdown of Sirt1 in Renal Cellsexpression of podocyte genesdNphs1, Synpo, CD2AP, WT-
1, Neph1, and Neph2dand histological features of glomeruli,
podocytes, podocyte foot processes, mesangial cells, glo-
merular endothelium, and tubular cells were also unaffected
by chronic Sirt1 knockdown (Figure 2, B and GeL).
To further conﬁrm that Sirt1 is dispensable for glomerular
function under the basal condition, we examined the renal
phenotype in two other Sirt1 gene deletion models: heterozy-
gous Sirt1-null mice (Sirt1þ/)30 and podocyte-conditional
Sirt1 deletion mice (PODDSirt1). Sirt1 was approximately 45%
lower in the renal cortex of 22-week-old Sirt1þ/ mice and
approximately 80% lower in PGECs of PODDSirt1 mice
compared with corresponding age-matched control mice
(Sirt1þ/þ mice and NPHS2-Cre mice) (Supplemental
Figure S3, AeD). Similar to CAGs;Sirt1RNAi mice with
chronic Sirt1 knockdown, Sirt1þ/ mice and PODDSirt1
mice did not develop any abnormality in renal histological
characteristics or urinary protein excretion when followed
up to 40 and 50weeks of age, respectively (data not shown).
Taken together, these data strongly suggest that up to anThe American Journal of Pathology - ajp.amjpathol.org80% reduction of Sirt1 in the podocyte and kidney, either
acutely or chronically, does not interfere with glomerular
function and development under the basal condition.
Mice with Inducible Podocyte- and Tubule-Speciﬁc
Sirt1 Knockdown
To study Sirt1 function in podocytes and tubular cells, we
generated double-transgenic mice with either podocyte-
or tubular-restricted Sirt1 knockdown (eg, POD;Sirt1RNAi
and TUB;Sirt1RNAi mice) (Figure 3A). Podocyte-speciﬁc
Sirt1 knockdown in POD;Sirt1RNAi mice was conﬁrmed
by colocalization of GFP with a podocyte cell surface
marker, podocalyxin (Supplemental Figure S4A). GFP
expression was also observed in PGECs of POD;Sirt1RNAi
mice that displayed highly arborized morphological charac-
teristics, but not in PGECs with a cobblestone appearance
(Figure 3B). These ﬁndings suggest that GFP expression and
Sirt1 knockdown are restricted to the podocytes of POD;-
Sirt1RNAi mice. To determine the magnitude of Sirt11947
Figure 5 Progression and reversibility of ADR
nephropathy in POD;Sirt1RNAi and TUB;Sir1RNAi
mice. A: A scheme of study design. B: UACR of mice
0, 14, and 28 days after ADR injection. *P < 0.05
versus UACR on D0. (N Z 7 POD;Sirt1RNAi mice in
both ADR þ DOX and ADR þ DOX_WD groups, and
N Z 8 TUB;Sirt1RNAi mice in both ADR þ DOX and
ADR þ DOX_WD groups). C: Serum creatinine levels
of mice after ADR injection. D: Representative im-
ages of PAS-stained kidney sections showing global
glomerulosclerosis (black arrows), segmental glo-
merulosclerosis (black arrowheads), normal
glomeruli (gray arrowheads), and dilated tubules
with protein casts. E: Representative electron mi-
croscopy images for POD;Sirt1RNAi mice showing
focal areas of effacement (red arrows) with areas of
normal FPs (black arrows). F: A bar graph of FP
width for POD;Sirt1RNAi mice. (NZ 3 mice in each
group of ADR þ DOX and ADR þ DOX_WD.)
*P < 0.05, ***P < 0.001. Scale barZ 50 mm (D).
P, podocytes.
Chuang et alknockdown in the podocytes, we isolated the GFP-positive
podocytes by FACS from POD;Sirt1RNAi mice and control
POD;LuciRNAi mice that have been fed DOX for 7 days
(Supplemental Figure S4B).We found that the Sirt1 transcript
level of GFP-positive podocytes, isolated from POD;Sirt1R-
NAimice, was 31.3% 1.27%of that fromPOD;LucRNAimice
(Figure 3C). To determine the speciﬁcity of Sirt1 knockdown
in TUB;Sirt1RNAi mice, we evaluated the pattern of GFP
expression in kidney sections and found that GFP was
expressed in the tubular compartment and absent from the
glomeruli of DOX-fed TUB;Sirt1RNAi mice (Supplemental
Figure S4C). Sirt1 expression in the kidney cortex of DOX-
fed TUB;Sirt1RNAi mice was approximately 70% lower than
TUB;Sirt1RNAi mice without DOX feeding (Figure 3D).1948Sirt1 Knockdown Enhances Susceptibility to ADR
Nephropathy
Because Sirt1 knockdown has no impact on glomerular
function under the basal condition, next we investigated
whether Sirt1 is required for the maintenance of glomerular
function in mice with ADR-induced nephropathy. ADR is
an anthracycline antibiotic. When injected into the tail vein
of mice, ADR causes podocyte damage and glomerular
injury. Proteinuria and glomerulosclerosis manifest as early
as 10 and 28 days after ADR injection, respectively.42
Mitochondrial function43 and autophagy response44 of
podocytes are key determinants of strain-dependent sus-
ceptibility to ADR. Because Sirt1 is known to regulateajp.amjpathol.org - The American Journal of Pathology
RNAi Knockdown of Sirt1 in Renal Cellsmitochondrial function and autophagy, we examined
whether CAGs;Sirt1RNAi mice with Sirt1 knockdown are
more susceptible to ADR-induced glomerular injury. DOX
was given to male CAGs;Sirt1RNAi mice 5 days before ADR
injection and continued until 10 days after ADR injection
(Figure 4A). CAGs;Sirt1RNAi mice with and without DOX
feeding were injected with 0.9% saline as a control. DOX-
fed and ADR-injected mice (ie, ADR þ DOX) lose more
body weight compared with all other groups of mice
(Supplemental Figure S5A). Urinary albumin excretion, as
assessed by Coomasie Blue staining of urinary proteins and
UACR, was signiﬁcantly more in the ADR þ DOX group
compared with the ADR-only group (1.860  0.42 versus
0.8  0.081 mg/mg; P < 0.05) (Figure 4, B and C). Serum
urea nitrogen of the ADR þ DOX group was also higher
than the ADR-only group (Supplemental Figure S5B),
whereas no signiﬁcant difference in serum creatinine was
observed (data not shown). Dilated renal tubules with
protein casts were present diffusely in the ADR þ DOX
kidneys (>50% of the tubular area), infrequently in the
ADR-only kidneys (<25% of the tubular area), and absent
in the saline-only and saline þ DOX kidneys (Figure 4D).
No obvious disruption of glomerular structure was observed
by light microscopy. Ultrastructural examination of the
podocyte foot processes (FPs), however, revealed that FP
width was signiﬁcantly wider in the ADR þ DOX group
compared with the ADR-only group (1240  41 nm versus
641  30 nm) (Figure 4, E and F). These data indicate that
Sirt1 deﬁciency exacerbates ADR-induced disruption of
podocyte FP organization and glomerular ultraﬁlter function
during the early phase of ADR-induced nephropathy.
Sirt1 in the Podocytes, But Not Tubules, Maintains
Glomerular Function in ADR Nephropathy
Because Sirt1 knockdown is widespread in CAGs;Sirt1RNAi
mice, it was not clear whether their susceptibility to ADR
nephropathy was due to Sirt1 knockdown in podocytes and/
or other renal cell types. To speciﬁcally address podocyte
Sirt1’s role in ADR nephropathy, we compared the pro-
gression of ADR nephropathy between POD;Sirt1RNAi and
TUB;Sirt1RNAi mice. The length of the experiment was
extended to 28 days after ADR injection to capture the
development of ADR-induced glomerulosclerosis. Simul-
taneously, we also investigated whether reversal of Sirt1
knockdown modiﬁes the progression of nephropathy. Male
POD;Sirt1RNAi and TUB;Sirt1RNAi mice were injected with
ADR and then fed DOX for either 14 or 28 days (Figure 5A).
Mice with a shorter duration of Sirt1 knockdown were fed
DOX for 14 days before withdrawal of DOX [ie, the
ADRþDOX_WD (doxycycline withdraw) group], andmice
with a longer duration of knockdown (ie, the ADR þ DOX
group) received DOX for all 28 days of the experiment. Mice
were observed for 28 days after ADR injection. On day 14,
the level of UACR was signiﬁcantly higher in both of the
POD;Sirt1RNAi groups (ADR þ DOX and ADR þ DOX_The American Journal of Pathology - ajp.amjpathol.orgWD) compared with the corresponding TUB;Sirt1RNAi
groups (Figure 5B). Between days 14 and 28, UACR
continued to increase for the ADR þ DOX group of POD;-
Sirt1RNAi mice, but remained unchanged for the ADR þ
DOX_WD group of POD;Sirt1RNAi mice as well as both
groups of TUB;Sirt1RNAi mice. Although serum creatinine
levels were not different between the four groups on day 14,
the creatinine level for the ADR þ DOX group of POD;-
Sirt1RNAi mice on day 28 was signiﬁcantly higher than all
other groups (Figure 5C). Segmental glomerulosclerosis was
observed in >75% of the glomeruli in the ADR þ DOX
group, in <25% of the glomeruli in the ADR þ DOX_WD
group, and in <10% of the glomeruli in either groups of
TUB;Sir1RNAi mice (Figure 5D). For the POD;Sirt1RNAi
mice, tubular dilation and tubular protein casts were observed
in>50% of the tubular lumen in the ADRþDOX group and
in<10% of the ADRþDOX_WD group. Tubular casts were
absent in both groups of TUB;Sirt1RNAi mice. Assessment of
podocyte FPs revealed focal areas of effacement in both
groups of POD;Sirt1RNAimice (Figure 5E). The width of FPs
was signiﬁcantly higher in the ADRþDOX group compared
with the ADRþDOX_WD group (Figure 5, E and F). These
ﬁndings suggest that Sirt1’s function in the podocyte, and not
tubular cells, contributes to CAGs;Sirt1RNAi mice’s suscep-
tibility to ADR. In addition, our data suggest that reversal of
Sirt1 knockdown 2 weeks after ADR injection prevented the
progression, but did not completely reverse the development,
of ADR-induced glomerulopathy.
Sirt1 Knockdown Enhances ADR-Induced Mitochondrial
Damage in Podocytes
To delineate the cellular mechanism that drives ADR-induced
renal injury inSirt1-deﬁcientmice,we focusedonADR-induced
mitochondrial damage. First,we conﬁrmed that 0.4mg/mLADR
exposure for 6 hours signiﬁcantly reduced the mitochondrial
DNA (mtDNA) content of primary PGECs isolated from mice
without Sirt1 knockdown (Figure 6A). ADR exposure was also
found to signiﬁcantly up-regulate the expression of genes
encoding essential mitochondrial proteins, including those
involved inmitochondrial respiration (Nrf1, Ndufa4, and Sco2),
mitochondrial reactive oxygen species metabolism (Mpv17 and
Sod2), and mtDNA transcription (Polrmt, Tfb1m, and Tfb2m)
(Figure 6B). Interestingly, the expression of Prkdc, which en-
codes a nuclear DNA double-stranded break repair protein that
prevents ADR-induced mtDNA damage and nephropathy,43
was signiﬁcantly increased by ADR. Sirt1 was also signiﬁ-
cantly increased by ADR treatment.
To examine the impact of ADR treatment on mitochon-
dria of podocytes with Sirt1 knockdown, we performed
mitochondrial staining using a mitochondrial membrane
potential-dependent probe, called MitoTracker (MTR; Life
Technologies). Cytoplasmic MTR staining was markedly
reduced by ADR treatment in podocytes without DOX-
induced Sirt1 knockdown (ADR group) and in podocytes
with DOX-induced Sirt1 knockdown (ADR þ DOX group)1949
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Figure 7 Markers of autophagy in POD;Sirt1RNAi podocytes treated with
ADR. A: Representative Western blot analyses of LC3, p62/SQSTM1, and
b-actin of POD;Sirt1RNAi podocytes with and without DOX-induced Sirt1
knockdown treated with ADR in the absence or presence of an autophagy
inhibitor, baﬁlomycin A. B: Band densitometric values of Western blot
analyses for LC3-II and p62 relative to b-actin and normalized to lane 1.
Values are averages from two sets of experiments. Black bars, p62/actin;
white bars, LC3-II/actin.
RNAi Knockdown of Sirt1 in Renal Cells(Figure 6C). Sirt1 knockdown alone (DOX), however, did
not reduce MTR staining. To determine whether the ADR-
induced decrease in MTR staining was due to a loss of
mitochondrial membrane potential or a reduction in mito-
chondrial number, we performed immunostaining for
TOM20, which is a mitochondrial outer membrane trans-
locase protein. We found that cytoplasmic staining of
TOM20 was not affected by ADR or DOX, either separately
or in combination (Figure 6D), suggesting that reduced
MTR staining in ADR-treated cells was more likely caused
by a loss of mitochondrial membrane potential rather than a
reduction in mitochondrial number (Figure 6D). A peri-
nuclear pattern of TOM20 and MTR labeling was observed
in the ADR and ADR þ DOX groups.
Autophagy is a key cellular mechanism for removal of
damaged mitochondria. Selective mitochondrial elimina-
tion by autophagy is mediated by an E3 ubiquitin ligase
called parkin. Parkin translocates to the mitochondrial outer
membrane on dissipation of the mitochondrial membrane
potential in response to oxidant stress and labels damaged
mitochondria for removal by autophagy.45 Because ADR
treatment induces mtDNA depletion and depolarization, we
examined whether ADR promotes autophagy of damaged
mitochondria and whether Sirt1 deﬁciency prevents ADR-
induced autophagy by studying the accumulation of par-
kin on TOM20-labeled mitochondria. We found that ADR
increased intracellular parkin-labeled puncti and the extent
of parkin and TOM20 colocalization (Figure 6D). ADR-
induced colocalization of parkin and TOM20, however,
was markedly reduced in Sirt1 knockdown cells (ie, the
ADR þ DOX group), suggesting that ADR-induced parkin
recruitment is an Sirt1-dependent process. To examine
Sirt1’s role on autophagy ﬂux in podocytes, we studied the
accumulation of lipidated LC3 (ie, LC3-II) and p62 in the
presence and absence of baﬁlomycin A1, which inhibits
degradation of autolysosome content. We observed that
podocytes have a high LC3-II/LC3-I ratio under the basal
condition (lane 1) (Figure 7), which is consistent with the
previous observation that podocytes in vivo exhibit a high
autophagy ﬂux.44 ADR treatment increased the accumula-
tion of both LC3-II and p62/SQSTM1 in the presence of
baﬁlomycin A1 compared with those without ADR treat-
ment (lane 3 versus 1) (Figure 7), which was abrogated in
DOX-treated cells with Sirt1 knockdown (lane 3 versus 4).
Taken together, these ﬁndings suggest that Sirt1 is required
to facilitate the ADR-triggered autophagy response. Inter-
estingly, ADR treatment alone did not markedly alter p62
expression in cells not treated with baﬁlomycin (lane 2
versus 1).Figure 6 Mitochondrial response of podocytes with Sirt1 knockdown to ADR t
0.4 mg/mL ADR treatment for 6 hours. Results from four independent experiments
for PGECs with and without ADR treatment. Results from at least ﬁve independen
mitochondrial membraneedependent MTR probe. D: Co-immunostaining of mito
(pseudocolored: white) antibodies, respectively. Inset, right panel: High-power
images. ADR, 0.4 mg/mL ADR for 6 hours; ADR þ DOX, dose and duration of treatm
for 48 hours. *P < 0.05, ***P < 0.001. Scale bar Z 20 mm (C and D); 5 mm (D
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Increasing the Glomerular Expression of Mitochondrial
Genes
To validate the in vitro observations, we compared the
expression of mitochondrial genes and the morphological
characteristics of mitochondria in ADR-injected POD;
Sirt1RNAi mice with Sirt1 knockdown. The mitochondria-to-
nuclear DNA content in glomeruli of POD;Sirt1RNAi mice
with a longer duration of Sirt1 knockdown (ADR þ DOX)
was signiﬁcantly lower than that of POD;Sirt1RNAi micereatment. A: mtDNA/nuclear DNA (nuDNA) ratio of PGECs with and without
. B: Relative expression of mitochondrial genes and other genes of interest
t experiments. C: Mitochondria staining of POD;Sirt1RNAi podocytes using a
chondria and a marker of mitophagy by anti-TOM20 (red) and anti-parkin
images of the area circumscribed by the dashed-line squares in the larger
ent same as previously described; Control, no treatment; DOX, 2 mg/mL DOX
, insets).
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Figure 8 Mitochondrial gene expression and morphological
characteristics in POD;Sirt1RNAi mice with podocyte Sirt1 knock-
down. A: A bar graph depicting mtDNA content normalized to nuDNA
in glomeruli of POD;Sirt1RNAi mice with (ADR þ DOX_WD) and
without (ADR þ DOX) reversal of Sirt1 knockdown. NZ 4 samples
per group. B: Electron microscopy images of mitochondria in
podocytes of POD;Sirt1RNAi mice. Green arrows indicate fragmented
mitochondria with loss of internal cristae structure; red arrows,
normal-appearing mitochondria with intact cristae; green arrow-
heads, early autophagosomes containing mitochondrial proﬁle
similar to an adjacent mitochondrion in the cytoplasm; red arrow-
heads, autophagosomes containing heterogeneous cytoplasmic
material. C: Normalized expressions of selected mitochondrial genes
in isolated glomeruli of POD;Sirt1RNAi mice with or without reversal
of Sirt1 knockdown. N Z 4 samples per group. **P < 0.01. Black
bars, ADRþDOX_WD; blue bars, ADRþDOX; FP, foot processes.
Chuang et alwith a shorter duration of Sirt1 knockdown (ADR þ
DOX_WD) (Figure 8A). Mitochondria of podocytes in the
ADR þ DOX group exhibited loss of internal cristae and
appeared more fragmented and swollen (Figure 8B). Early
autophagosomes containing heterogeneous cytoplasmic
material were observed in both ADR þ DOX and ADR þ
DOX_WD podocytes, but appeared less abundant in the
ADR þ DOX group. Taken together, these ﬁndings suggest
that prolonged knockdown of Sirt1 reduces the glomerular
mtDNA content, increases the accumulation of dysmorphic
mitochondria, and prevents formation of autophagosomes in
ADR-treated mice.
Because Sirt1 also activates PGC1a, which is a master
regulator of mitochondrial gene transcription and mito-
chondrial biogenesis,46,47 we compared the glomerular
expression of mitochondrial genes in ADR-injected POD;-
Sirt1RNAi mice. Glomerular expression of nuclear DNA-
encoded mitochondrial genes in podocytes (Nrf1, Ndufa4,
Sco2, Mpv17, Sod3, Polrmt, Tfb1m, and Tfb2m) that were
up-regulated and in podocytes treated with ADR in vitro
were not signiﬁcantly different between ADR þ DOX_WD
and ADR þ DOX groups (Figure 8C). Speciﬁcally, the1952glomerular expression of mitochondrial genes important
for mitochondrial biogenesisdNrf1, Tfb1m, and Tfb2md
was not different between ADR þ DOX_WD and ADR þ
DOX.
Sirt1 Deﬁciency Promotes Mitochondrial Injury of
Glomerular Cells in Diabetic Mice
Because a pathogenic role for Sirt1 in diabetic nephropathy
has been reported by us and others18e20,22 and mitochon-
drial dysfunction is involved in the pathogenesis of diabetic
kidney injury,48,49 we evaluated the progression of diabetic
nephropathy in CAGs;Sirt1RNAi mice with and without Sirt1
knockdown (STZ þ DOX and STZ, respectively). Diabetes
mellitus was induced in these mice between 6 and 7 weeks
of age by multiple low-dose STZ injections (Figure 9). Mice
were followed up for 20 weeks after the start of STZ in-
jections (Figure 9A). Four-hour fasting serum glucose
levels, body weights, kidney/body weight ratio, systolic
blood pressures, and serum creatinine concentration were
measured at the end of 20 weeks of observation and were
not signiﬁcantly different between STZ and STZ þ DOXajp.amjpathol.org - The American Journal of Pathology
Figure 9 Diabetic CAGs;Sirt1RNAimice with Sirt1 knockdown. A: A scheme
depicting the experimental design for determining the impact of STZ-induced
diabetes on the development of nephropathy in CAGs;Sirt1RNAi mice with and
without DOX-induced Sirt1 knockdown (STZþ DOX and STZ, respectively). B:
Urinary albumin/creatinine ratio of mice 20 weeks after the start of STZ in-
jections. C: PAS-stained kidney sections. Adjacent bar graph depicts the
percentage of mesangial area/glomerular tuft area in the two groups of mice.
D: TEMs of mitochondria within podocytes. Arrowheads indicate round,
fragmented mitochondria with absence of internal cristae structure; arrows,
long ﬁlamentous mitochondria. E: Glomerular expression of mitochondrial
genes. *P < 0.05, **P < 0.01. Scale bars: 50 mm (C); 1 mm (D).
Table 2 Physiological and Biochemical Parameters of Diabetic
CAGs;Sirt1RNAi Mice 20 Weeks after STZ Injection
Parameter STZ (n Z 4)
STZ þ DOX
(n Z 6)
4-Hour fasting serum glucose
(mg/dL)
409  71 416  59
Body weight (g) 35.3  4.0 35.7  1.9
Kidney weight/body weight (mg/g) 9.6  0.95 10.8  0.10
Systolic BP (mmHg) 134  5 141  9
Serum creatinine (mg/dL) 0.13  0.01 0.14  0.01
Values are expressed as means  SEM. No statistically signiﬁcant dif-
ferences were observed between the STZ and STZ þ DOX groups of mice at
the time of sacriﬁce (20 weeks after STZ injection).
RNAi Knockdown of Sirt1 in Renal Cellsgroups (Table 2). However, urinary albumin excretion was
signiﬁcantly higher in the STZ þ DOX mice compared with
STZ mice (1.99  0.22 versus 0.74  0.11 mg albumin/mg
creatinine; PZ 0.0063) (Figure 9B). In addition, mesangial
matrix area of the STZ þ DOX group was signiﬁcantly
higher than the STZ group (mesangial area per glomerular
tuft area, 42.4% 1.5% versus 31.4% 1.2%; PZ 0.0004)
(Figure 9C). Ultrastructural evaluation of the mitochondria
in podocytes revealed numerous mitochondria with a smaller
aspect ratio and loss of internal cristae (Figure 9D), which are
suggestive of mitochondrial fragmentation, in the STZ þ
DOX group, whereas the long ﬁlamentous mitochondria
were observed in the STZ group (Figure 9D). Glomerular
mRNA expression of genes involved in mitochondrial gene
transcription (Nrf1, Mterf, and Tfb2m) and mtDNA replica-
tion (Peo1/twinkle) was signiﬁcantly lower in the STZ þ
DOX group (Figure 9D). Together, these ﬁndings provide
further validation that Sirt1 deﬁciency plays a pathogenicThe American Journal of Pathology - ajp.amjpathol.orgrole in another experimental model, in which mitochondrial
injury is critically involved in the pathogenesis of glomerular
disease.
Discussion
Herein, we generated and validated several lines of geneti-
cally engineered mice exhibiting tissue-speciﬁc, DOX-
inducible knockdown of Sirt1 expression in a reversible
manner. We demonstrated that post-natal Sirt1 reduction,
either acutely or chronically, widespread or restricted to the
kidneys, does not interfere with glomerular function. How-
ever, we determined that Sirt1 plays a key role in autophagy
of mitochondria in podocytes of mice with ADR nephropathy
and diabetic nephropathy.
Conditional and inducible gene deletion models for the
podocytes have been described previously.50,51 However,
these inducible gene reduction models rely on Cre-mediated
recombination, which involves irreversible and direct modi-
ﬁcation of the gene of interest. Gene knockdown by RNAi, on
the other hand, is reversible and does not involve direct
modiﬁcation to the gene of interest. Thus, this model is
appropriate for rescue experiments in which the investigator
can examine the impact that reversal of gene knockdown in
mice with established pathological features has on the course
of disease. Others have proposed the application of an in vivo
RNAi approach in renal research,52,53 but we are not aware of
any successful attempts in the published literature. Our model
is uniquely suited for studying kidney podocyte- and tubule-
speciﬁc roles of Sirt1 in disease processes, as we demonstrated
herein with ADR nephropathy. Herein, we observed that
diabetic mice with widespread Sirt1 knockdown manifested
early features of diabetic nephropathy after 20 weeks of hy-
perglycemia, including mesangial matrix accumulation and
albuminuria, as well as alterations in the mitochondrial
morphological characteristics and gene expression. These
ﬁndings in mice with widespread Sirt1 knockdown are
consistent with a recent study showing that Sirt1 deﬁciency in
the tubular cells promotes diabetic albuminuria18 and our own
observation that podocyte-speciﬁc Sirt1 deletion aggravates
albuminuria in diabetic db/db mice.20 Although over-
expression of Sirt1 in the proximal tubules of transgenic mice1953
Chuang et alprevents the development of albuminuria in diabetic mice,18 it
remains to be determinedwhether reversal of Sirt1 knockdown
in our model and overexpression of Sirt1 in podocytes can
prevent or reverse the development of diabetic nephropathy.
A podocyte is a post-mitotic, terminally differentiated cell
with a limited capacity for cell division. As such, dependence
on homeostatic mechanisms to cope with cellular stress, such
as ADR-induced mitochondrial stress, is critical to prevent
ampliﬁcation of the initial stressor, which otherwise would
further impair the respiratory chain or promote mutations in
mitochondrial DNA54 and could ultimately contribute to cell
death. The essential role of mitochondrial quality control in
podocytes is highlighted by our study. Herein, we elicited
the critical role served by Sirt1 in podocytes by imposing
ADR-induced genotoxic stress on the mitochondrial genome.
Knocking down Sirt1 in podocytes markedly diminished
the podocyte’s ability to cope with ADR-induced and
diabetes-related mitochondrial damage. Although Sirt1 is
known to protect against tubular injury,15e17micewith tubule-
restricted Sirt1 knockdown (TUB;Sirt1RNAi mice) were not
susceptible to ADR nephropathy, which was not unexpected,
especially because ADR is only known to affect podocytes55
and glomerular endothelial cells,56 but not tubular cells.
Mitochondrial biogenesis is a mechanism to replenish
mitochondrial number. Sirt1 controls activation of PGC1a,
which is a key regulator of mitochondrial biogenesis.
Although POD-Sirt1RNAi mice with a shorter duration of
Sirt1 knockdown developed less glomerular injury compared
with mice with a longer duration of knockdown, we did not
observe a signiﬁcant difference in the expression of mito-
chondrial genes between these two groups of mice. The lack
of a difference in glomerular expression of mitochondrial
genes, however, does not exclude Sirt1/PGC1a-mediated
mitochondrial biogenesis as a contributingmechanism for the
difference in glomerular injury betweenmice with shorter and
longer duration of Sirt1 knockdown: First, isolated glomeruli
were used to determine mitochondrial gene expression, not
isolated podocytes. Because podocytes constitute only a small
fraction of the cellular mass in the glomerulus, isolated glo-
merulidwhich are an aggregate of at least three different cell
types (podocytes, endothelial cells, and mesangial cells)d
might not reﬂect gene expression on the level of the podocytes.
Second, sampleswere obtained frommice at the termination of
the experiment (ie, 28 days after ADR injection) when
considerable glomerulosclerosis and reduction in glomerular
cells have developed in the ADRþDOX group. The pattern
of gene expression 28 days after ADR injection might not
reﬂect acute cellular response to ADR-induced mitochon-
drial damage. It is possible that mitochondrial biogenesis
was present during the acute, and not the chronic, phase of
ADR-induced injury. Because of these methodological
limitations, we are unable to completely exclude that
podocyte Sirt1 regulates mitochondrial biogenesis.
Mitochondrial ﬁssion is another mechanism to generate
new mitochondria. Fission is critical for dividing cells to
populate them with an adequate number of mitochondria.1954However, the role of ﬁssion in non-proliferating cells, such
as podocytes, is less clear. Fission and fusion appear to be
closely linked to autophagic removal of damaged mito-
chondria.57,58 Herein, we observed an accumulation of
fragmented mitochondria in ADR-treated mice with Sirt1
knockdown. Although mitochondrial ﬁssion is observed
under conditions of cellular stress and exaggerated ﬁssion
can facilitate apoptosis during high levels of cellular stress,
mitochondrial ﬁssion per se is not detrimental to cell sur-
vival. Accumulation of fragmented mitochondria could be
consistent with either increased ﬁssion or a lack of removal
of fragmented mitochondria by autophagy. In our model, the
lack of parkin recruitment to mitochondria of podocytes
with Sirt1 knockdown suggests that accumulation of frag-
mented mitochondria was likely due to impaired autophagy.
In conclusion, we generated and validated in vivo RNAi
models with spatial and temporal control of Sirt1 expres-
sion. We found that Sirt1 is dispensable for podocyte and
glomerular function under the basal condition. We also
identiﬁed that podocyte Sirt1 is critical for coping with
ADR-induced and diabetes-related damage by facilitating
the removal of damaged mitochondria.Acknowledgments
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